Merola, Joseph F.
Herrera, Vivian
Palmer, Jacqueline B.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 12 November 2017
Revised: 21 June 2018
Accepted: 24 June 2018
First Online: 26 July 2018
Compliance with ethical standards
:
: Vivian Herrera is an employee of Novartis Pharmaceutical Corporation and owns stock/stock options. Jacqueline B. Palmer is an employee of Novartis Pharmaceutical Corporation. Dr. Merola received funding support from the following corporate entities in the biotechnology/pharmaceutical sector: Biogen IDEC (research investigator funding, research grant, advisor board fees, consultant fees); AbbVie (Speaker fees, advisory board fees, licensed outcome measures funding); Amgen (advisor board fees, research investigator funding); Eli Lilly (advisor board fees, consultant fees); Novartis (advisor board fees, consultant fees); Pfizer (research investigator funding); Janssen (advisory board fees); and Momenta (consultant fees).